Negocios · 21/6/20191 min de lectura
Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee; Amendment of Notice
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee. This meeting was announced in the Federal Register of May 6, 2019. The amendment is being made to reflect a change in the DATES, Agenda, and Procedure portions of the document. There are no other changes.